Mirna Therapeutics

Developing microRNA-based oncology therapies for solid and hematologic cancers

placeAustin, Texas, United States calendar_todayFounded 2007 groups27 employees language mirnarx.com

Registered entities

Investor mix

13 investors on record; lead investors include Sofinnova Investments, Baxter; 2 have since exited.

Investor typeCountShare
Venture capital646%
Private equity18%
Other / undisclosed646%
Coming soon